i think the debt is due to the ARN purchase. I dont think debt is the real issue with this stock, its not highly geared!......the issue is revenue growth pure and simple, costs seem well explained....
- Forums
- ASX - By Stock
- SWM
- Ann: Presentation of Half Year Results
Ann: Presentation of Half Year Results, page-6
Featured News
Add SWM (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.3¢ |
Change
-0.003(1.52%) |
Mkt cap ! $253.9M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $9.551K | 58.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 719625 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 72270 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 719625 | 0.160 |
8 | 245788 | 0.155 |
18 | 192587 | 0.150 |
1 | 4000 | 0.145 |
8 | 170500 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 72272 | 16 |
0.170 | 838111 | 12 |
0.175 | 300812 | 15 |
0.180 | 845893 | 12 |
0.185 | 768323 | 5 |
Last trade - 12.34pm 12/11/2024 (20 minute delay) ? |
Featured News
SWM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online